Kestra Advisory Services LLC Has $29.25 Million Stock Position in Stryker Corporation $SYK

Kestra Advisory Services LLC boosted its holdings in Stryker Corporation (NYSE:SYK) by 4.8% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 89,002 shares of the medical technology company’s stock after acquiring an additional 4,093 shares during the quarter. Kestra Advisory Services LLC’s holdings in Stryker were worth $29,245,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Godfrey Financial Associates Inc. bought a new position in shares of Stryker in the fourth quarter valued at approximately $26,000. Sankala Group LLC bought a new stake in Stryker during the fourth quarter worth $26,000. United Financial Planning Group LLC bought a new stake in Stryker during the third quarter worth $27,000. Atlas Capital Advisors Inc. purchased a new stake in Stryker in the 4th quarter valued at $27,000. Finally, DJE Kapital AG bought a new position in Stryker during the 4th quarter valued at $28,000. 77.09% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently issued reports on SYK. Truist Financial reiterated a “hold” rating and issued a $330.00 target price (down from $380.00) on shares of Stryker in a research note on Monday, May 4th. Robert W. Baird set a $385.00 price target on shares of Stryker in a research report on Friday, May 1st. Canaccord Genuity Group cut their price target on shares of Stryker from $435.00 to $400.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Wall Street Zen downgraded shares of Stryker from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Weiss Ratings lowered shares of Stryker from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $392.87.

Insider Buying and Selling at Stryker

In other news, VP M Kathryn Fink sold 5,220 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $283.85, for a total transaction of $1,481,697.00. Following the completion of the transaction, the vice president directly owned 13,137 shares of the company’s stock, valued at $3,728,937.45. This represents a 28.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ronda E. Stryker sold 310,000 shares of Stryker stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the completion of the sale, the director directly owned 1,924,880 shares in the company, valued at $601,005,282.40. This trade represents a 13.87% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 323,264 shares of company stock worth $100,659,489 over the last three months. 4.60% of the stock is currently owned by insiders.

Stryker Stock Performance

NYSE:SYK traded up $2.75 during trading on Friday, reaching $329.86. The company’s stock had a trading volume of 2,724,614 shares, compared to its average volume of 2,471,298. Stryker Corporation has a 12 month low of $281.00 and a 12 month high of $404.87. The firm has a market cap of $126.46 billion, a price-to-earnings ratio of 38.18, a price-to-earnings-growth ratio of 2.10 and a beta of 0.77. The firm has a 50 day moving average of $310.12 and a 200-day moving average of $337.97. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11.

Stryker (NYSE:SYK) last released its earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The business had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Research analysts expect that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be given a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s payout ratio is currently 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.